{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:20:39Z","timestamp":1787318439251,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical cancer remains a major global health burden among women. Persistent infection with high-risk human papillomavirus (HR-HPV) is the primary driver of cervical carcinogenesis, yet additional cellular regulatory processes are required for tumor progression. Ferroptosis, an iron-dependent form of regulated cell death, has been implicated in cancer metabolism and therapeutic response. However, the involvement of ferroptosis-related long non-coding RNAs (FRLs) in human papillomavirus (HPV)-associated cervical cancer remains insufficiently understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Transcriptomic and clinical data from The Cancer Genome Atlas (TCGA) and UCSC Xena were analyzed to identify FRLs. A prognostic risk-scoring model (RSM) was constructed using LASSO Cox regression and evaluated by survival analysis and time-dependent receiver operating characteristic (ROC) curves. Expression patterns of selected FRLs were further examined in cervical swab samples with different HPV infection subtypes using quantitative polymerase chain reaction (qPCR). Functional validation was performed in HPV16-positive SiHa cells following small interfering RNA (siRNA)-mediated knockdown of LINC02178, combined with ferroptosis modulation using Erastin or Ferrostatin-1. Cell viability, migration, and ferroptosis-associated biochemical indicators were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A prognostic model based on 22 FRLs showed stable predictive performance and remained an independent prognostic factor after adjustment for clinical variables. Among these FRLs, LINC02178 emerged as a standout risk factor, exhibiting markedly elevated expression in HPV16-positive tissues and a strong positive correlation with the lipid droplet-associated protein PLIN2\u2014suggesting a potential role in lipid metabolism.\n                      <jats:italic>In vitro<\/jats:italic>\n                      experiments demonstrated that LINC02178 knockdown inhibited cell proliferation and migration. Furthermore, silencing LINC02178 increased cellular susceptibility to ferroptosis, as reflected by altered redox status and enhanced oxidative stress, particularly under erastin treatment, evidenced by surging levels of reactive oxygen species (ROS), malondialdehyde (MDA), and ferrous iron accumulation (Fe\u00b2\n                      <jats:sup>+<\/jats:sup>\n                      ) alongside depleted glutathione (GSH). These findings suggest that LINC02178 potentially serves as a critical metabolic shield, contributing to the ability of HPV-infected cells to evade ferroptosis and sustain tumor progression.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1807953","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:55:29Z","timestamp":1778219729000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A ferroptosis-related lncRNAs risk score model identifies LINC02178 as a potential regulator of ferroptosis sensitivity in cervical cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Huasu","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]},{"name":"Scientific Research Center, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaokun","family":"She","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]},{"name":"Scientific Research Center, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]},{"name":"Scientific Research Center, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]},{"name":"Scientific Research Center, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]},{"name":"Scientific Research Center, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudi","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]},{"name":"Scientific Research Center, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]},{"name":"Scientific Research Center, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengfei","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zha","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People\u2019s Hospital of Zunyi)","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.52.6.320","article-title":"CA: A cancer journal for clinicians--what's new and what's not","volume":"52","author":"Gansler","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2021.06.009","article-title":"Lipid metabolism and oxidative stress in HPV-related cancers","volume":"172","author":"Cruz-Gregorio","year":"2021","journal-title":"Free Radical Biol Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003048","article-title":"Emerging mechanisms of ferroptosis and its implications in lung cancer","volume":"137","author":"Li","year":"2024","journal-title":"Chin Med J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000390","article-title":"Ferroptosis in hepatocellular carcinoma: from bench to bedside","volume":"80","author":"Tang","year":"2024","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2521","article-title":"Long non-coding RNAs: insights into functions","volume":"10","author":"Mercer","year":"2009","journal-title":"Nat Rev Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41580-023-00694-9","article-title":"Transcription regulation by long non-coding RNAs: mechanisms and disease relevance","volume":"25","author":"Ferrer","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-00998-x","article-title":"Non-coding RNAs and ferroptosis: potential implications for cancer therapy","volume":"29","author":"Balihodzic","year":"2022","journal-title":"Cell Death Differ"},{"key":"B17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41419-020-02772-8","article-title":"Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41419-022-05192-y","article-title":"Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2","volume":"13","author":"Han","year":"2022","journal-title":"Cell Death Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0085-z","article-title":"Dynamics and functions of lipid droplets","volume":"20","author":"Olzmann","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092188","article-title":"PI3K\/AKT\/mTOR signaling regulates the virus\/host cell crosstalk in HPV-positive cervical cancer cells","volume":"20","author":"Bossler","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02290-6","article-title":"Deciphering the mechanisms of long non-coding RNAs in ferroptosis: insights into its clinical significance in cancer progression and immunology","volume":"11","author":"Ou","year":"2025","journal-title":"Cell Death Discov"},{"key":"B25","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41419-022-05173-1","article-title":"LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7465880","article-title":"Ferroptosis-related lncRNA signature correlates with the prognosis, tumor microenvironment, and therapeutic sensitivity of esophageal squamous cell carcinoma","volume":"2022","author":"Zhu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189292","article-title":"Exploring the metabolic alterations in cervical cancer induced by HPV oncoproteins: from mechanisms to therapeutic targets","volume":"1880","author":"Gore","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202414018","article-title":"HPV E6\/E7-induced acetylation of a peptide encoded by a long non-coding RNA inhibits ferroptosis to promote the Malignancy of cervical cancer","volume":"12","author":"Qi","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2623-z","article-title":"Lymph protects metastasizing melanoma cells from ferroptosis","volume":"585","author":"Ubellacker","year":"2020","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","article-title":"Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects","volume":"33","author":"Dierge","year":"2021","journal-title":"Cell Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1186\/s12885-022-10232-z","article-title":"M7G-related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma","volume":"22","author":"Pan","year":"2022","journal-title":"BMC Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"39344","DOI":"10.1038\/s41598-025-22922-2","article-title":"LINC02178 drives lung adenocarcinoma progression and serves as a therapeutic target for nanodelivery-based intervention","volume":"15","author":"Zeng","year":"2025","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41420-022-01013-5","article-title":"Persistent ferroptosis promotes cervical squamous intraepithelial lesion development and oncogenesis by regulating KRAS expression in patients with high risk-HPV infection","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Discov"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1807953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:55:30Z","timestamp":1778219730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1807953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":34,"alternative-id":["10.3389\/fonc.2026.1807953"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1807953","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1807953"}}